Muscarinic Acetylcholine Receptor Market 2027 Type, Application | The Insight Partners

Muscarinic Acetylcholine Receptor Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ( M1, M4, M5, Others ); Application ( Chronic Obstructive Pulmonary Disease, Attention Deficit Hyperactivity Disorder, Alzheimerâ™s Disease, Memory Impairment, Psychiatric Disorders )

Report Code: TIPRE00010927 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Muscarinic acetylcholine receptors are a subtype of acetylcholine receptors. In the cell membranes of certain neurons and other cells, these cells form G protein-receptor complexes. These receptors are activated in the presence of acetylcholine that are released from postganglionic fibers in the parasympathetic nervous system. Acetylcholine acts as neurotransmitters in the peripheral nervous system and central nervous system. Acetylcholine activates muscles in the peripheral nervous system and causes excitatory actions in the central nervous system.

MARKET DYNAMICS

The muscarinic acetylcholine receptor market is driving due to the rise in the incidence of these diseases will increase the demand for muscarinic acetylcholine receptors. However, stringent government regulations restraint the market growth during the forecast period. Moreover, the increased R&D activity for the therapeutic contribution of these receptors will help boost the market growth.

MARKET SCOPE

The "Muscarinic Acetylcholine Receptor Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of muscarinic acetylcholine receptor market with detailed market segmentation by type and, application. The muscarinic acetylcholine receptor market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in muscarinic acetylcholine receptor market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The muscarinic acetylcholine receptor market is segmented on the basis of type and application. Based on type, the market is segmented as M1, M4, M5, and others. On the basis of application, the market is categorized as chronic obstructive pulmonary disease, attention deficit hyperactivity disorder, alzheimerâ™s disease, memory impairment, and psychiatric disorders.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the muscarinic acetylcholine receptor market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The muscarinic acetylcholine receptor market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting muscarinic acetylcholine receptor market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the muscarinic acetylcholine receptor market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the muscarinic acetylcholine receptor market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from muscarinic acetylcholine receptor market are anticipated to have lucrative growth opportunities in the future with the rising demand for muscarinic acetylcholine receptor in the global market. Below mentioned is the list of few companies engaged in the muscarinic acetylcholine receptor market.

The report also includes the profiles of key players in muscarinic acetylcholine receptor market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


    - Anavex Life Sciences Corp.
    - AstraZeneca Plc.
    - Elsevier B.V.
    - Eurofins DiscoverX Corporation
    - Heptares Therapeutics Ltd.
    - Karuna Pharmaceuticals Inc.
    - Merck KGaA
    - NeuroHealing Pharmaceuticals Inc.
    - Novus Biologicals
    - Sumitomo Dainippon Pharma Co. Ltd.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Muscarinic Acetylcholine Receptor Market - By Type
1.3.2 Muscarinic Acetylcholine Receptor Market - By Application
1.3.3 Muscarinic Acetylcholine Receptor Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET - GLOBAL MARKET ANALYSIS
6.1. MUSCARINIC ACETYLCHOLINE RECEPTOR - GLOBAL MARKET OVERVIEW
6.2. MUSCARINIC ACETYLCHOLINE RECEPTOR - GLOBAL MARKET AND FORECAST TO 2020
6.3. MARKET POSITIONING/MARKET SHARE
7. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET - REVENUE AND FORECASTS TO 2020 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. M1
7.3.1. Overview
7.3.2. M1 Market Forecast and Analysis
7.4. M4
7.4.1. Overview
7.4.2. M4 Market Forecast and Analysis
7.5. M5
7.5.1. Overview
7.5.2. M5 Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET - REVENUE AND FORECASTS TO 2020 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
8.3.1. Overview
8.3.2. Chronic Obstructive Pulmonary Disease Market Forecast and Analysis
8.4. ATTENTION DEFICIT HYPERACTIVITY DISORDER
8.4.1. Overview
8.4.2. Attention Deficit Hyperactivity Disorder Market Forecast and Analysis
8.5. ALZHEIMERâ™S DISEASE
8.5.1. Overview
8.5.2. Alzheimerâ™s Disease Market Forecast and Analysis
8.6. MEMORY IMPAIRMENT
8.6.1. Overview
8.6.2. Memory Impairment Market Forecast and Analysis
8.7. PSYCHIATRIC DISORDERS
8.7.1. Overview
8.7.2. Psychiatric Disorders Market Forecast and Analysis
9. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET REVENUE AND FORECASTS TO 2020 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Muscarinic Acetylcholine Receptor Market Overview
9.1.2 North America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis
9.1.3 North America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Type
9.1.4 North America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Application
9.1.5 North America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Muscarinic Acetylcholine Receptor Market
9.1.5.1.1 United States Muscarinic Acetylcholine Receptor Market by Type
9.1.5.1.2 United States Muscarinic Acetylcholine Receptor Market by Application
9.1.5.2 Canada Muscarinic Acetylcholine Receptor Market
9.1.5.2.1 Canada Muscarinic Acetylcholine Receptor Market by Type
9.1.5.2.2 Canada Muscarinic Acetylcholine Receptor Market by Application
9.1.5.3 Mexico Muscarinic Acetylcholine Receptor Market
9.1.5.3.1 Mexico Muscarinic Acetylcholine Receptor Market by Type
9.1.5.3.2 Mexico Muscarinic Acetylcholine Receptor Market by Application
9.2. EUROPE
9.2.1 Europe Muscarinic Acetylcholine Receptor Market Overview
9.2.2 Europe Muscarinic Acetylcholine Receptor Market Forecasts and Analysis
9.2.3 Europe Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Type
9.2.4 Europe Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Application
9.2.5 Europe Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Muscarinic Acetylcholine Receptor Market
9.2.5.1.1 Germany Muscarinic Acetylcholine Receptor Market by Type
9.2.5.1.2 Germany Muscarinic Acetylcholine Receptor Market by Application
9.2.5.2 France Muscarinic Acetylcholine Receptor Market
9.2.5.2.1 France Muscarinic Acetylcholine Receptor Market by Type
9.2.5.2.2 France Muscarinic Acetylcholine Receptor Market by Application
9.2.5.3 Italy Muscarinic Acetylcholine Receptor Market
9.2.5.3.1 Italy Muscarinic Acetylcholine Receptor Market by Type
9.2.5.3.2 Italy Muscarinic Acetylcholine Receptor Market by Application
9.2.5.4 Spain Muscarinic Acetylcholine Receptor Market
9.2.5.4.1 Spain Muscarinic Acetylcholine Receptor Market by Type
9.2.5.4.2 Spain Muscarinic Acetylcholine Receptor Market by Application
9.2.5.5 United Kingdom Muscarinic Acetylcholine Receptor Market
9.2.5.5.1 United Kingdom Muscarinic Acetylcholine Receptor Market by Type
9.2.5.5.2 United Kingdom Muscarinic Acetylcholine Receptor Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Overview
9.3.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Forecasts and Analysis
9.3.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Muscarinic Acetylcholine Receptor Market
9.3.5.1.1 Australia Muscarinic Acetylcholine Receptor Market by Type
9.3.5.1.2 Australia Muscarinic Acetylcholine Receptor Market by Application
9.3.5.2 China Muscarinic Acetylcholine Receptor Market
9.3.5.2.1 China Muscarinic Acetylcholine Receptor Market by Type
9.3.5.2.2 China Muscarinic Acetylcholine Receptor Market by Application
9.3.5.3 India Muscarinic Acetylcholine Receptor Market
9.3.5.3.1 India Muscarinic Acetylcholine Receptor Market by Type
9.3.5.3.2 India Muscarinic Acetylcholine Receptor Market by Application
9.3.5.4 Japan Muscarinic Acetylcholine Receptor Market
9.3.5.4.1 Japan Muscarinic Acetylcholine Receptor Market by Type
9.3.5.4.2 Japan Muscarinic Acetylcholine Receptor Market by Application
9.3.5.5 South Korea Muscarinic Acetylcholine Receptor Market
9.3.5.5.1 South Korea Muscarinic Acetylcholine Receptor Market by Type
9.3.5.5.2 South Korea Muscarinic Acetylcholine Receptor Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Muscarinic Acetylcholine Receptor Market Overview
9.4.2 Middle East and Africa Muscarinic Acetylcholine Receptor Market Forecasts and Analysis
9.4.3 Middle East and Africa Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Muscarinic Acetylcholine Receptor Market
9.4.5.1.1 South Africa Muscarinic Acetylcholine Receptor Market by Type
9.4.5.1.2 South Africa Muscarinic Acetylcholine Receptor Market by Application
9.4.5.2 Saudi Arabia Muscarinic Acetylcholine Receptor Market
9.4.5.2.1 Saudi Arabia Muscarinic Acetylcholine Receptor Market by Type
9.4.5.2.2 Saudi Arabia Muscarinic Acetylcholine Receptor Market by Application
9.4.5.3 U.A.E Muscarinic Acetylcholine Receptor Market
9.4.5.3.1 U.A.E Muscarinic Acetylcholine Receptor Market by Type
9.4.5.3.2 U.A.E Muscarinic Acetylcholine Receptor Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Muscarinic Acetylcholine Receptor Market Overview
9.5.2 South and Central America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis
9.5.3 South and Central America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Type
9.5.4 South and Central America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Application
9.5.5 South and Central America Muscarinic Acetylcholine Receptor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Muscarinic Acetylcholine Receptor Market
9.5.5.1.1 Brazil Muscarinic Acetylcholine Receptor Market by Type
9.5.5.1.2 Brazil Muscarinic Acetylcholine Receptor Market by Application
9.5.5.2 Argentina Muscarinic Acetylcholine Receptor Market
9.5.5.2.1 Argentina Muscarinic Acetylcholine Receptor Market by Type
9.5.5.2.2 Argentina Muscarinic Acetylcholine Receptor Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MUSCARINIC ACETYLCHOLINE RECEPTOR MARKET, KEY COMPANY PROFILES
12.1. ANAVEX LIFE SCIENCES CORP.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELSEVIER B.V.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EUROFINS DISCOVERX CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HEPTARES THERAPEUTICS LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. KARUNA PHARMACEUTICALS INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK KGAA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NEUROHEALING PHARMACEUTICALS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVUS BIOLOGICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUMITOMO DAINIPPON PHARMA CO. LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Anavex Life Sciences Corp.
2. AstraZeneca Plc.
3. Elsevier B.V.
4. Eurofins DiscoverX Corporation
5. Heptares Therapeutics Ltd.
6. Karuna Pharmaceuticals Inc.
7. Merck KGaA
8. NeuroHealing Pharmaceuticals Inc.
9. Novus Biologicals
10. Sumitomo Dainippon Pharma Co. Ltd.
TIPRE00010927
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking